THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
D000293:Adolescent; D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D003523:Cycloserine; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D005000:Ethionamide; D006529:Hepatomegaly; D007538:Isoniazid; D007612:Kanamycin; D008111:Liver Function Tests; D010600:Pharmacology; D011718:Pyrazinamide; D014116:Toxicology; D014376:Tuberculosis; D018088:Tuberculosis, Multidrug-Resistant; D014397:Tuberculosis, Pulmonary; D014756:Viomycin
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D010131:Aminosalicylic Acid; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D014756:Viomycin
ADOLESCENCE; AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ETHIONIAMIDE; HEPATOMEGALY; ISONIAZID; KANAMYCIN; LIVER FUNCTION TESTS; PHARMACOLOGY; PYRAZINAMIDE; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY; VIOMYCIN